Link between GIP and osteopontin in adipose tissue and insulin resistance

Diabetes

Volumn 62, Issue 6, 2013, Pages 2088-2094

  Ahlqvist, Emma ^a   Osmark, Peter ^a   Kuulasmaa, Tiina ^b   Pilgaard, Kasper ^c   Omar, Bilal ^d   Brøns, Charlotte ^c   Kotova, Olga ^a   Zetterqvist, Anna V ^a   Stančáková, Alena ^e   Jonsson, Anna ^a   Hansson, Ola ^a   Kuusisto, Johanna ^e   Kieffer, Timothy J ^f   Tuomi, Tiinamaija ^g,h   Isomaa, Bo ^g,i   Madsbad, Sten ^j   Gomez, Maria F ^a   Poulsen, Pernille ^c   Laakso, Markku ^e   Degerman, Eva ^d   Pihlajamäki, Jussi ^b,e   Wierup, Nils ^k   Vaag, Allan ^c,j   Groop, Leif ^a,l   Lyssenko, Valeriya ^a   more..

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c STENO DIABETES CENTER   (Denmark)

^d LUND UNIVERSITY   (Sweden)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g FOLKHÄLSAN RESEARCH CENTER   (Finland)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ University of Copenhagen ^*  (Finland)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k LUND UNIVERSITY   (Sweden)

^l UNIVERSITY OF HELSINKI   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; MESSENGER RNA; OSTEOPONTIN;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ALLELE; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; EXON; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLISM; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; ALLELES; ANIMALS; CELLS, CULTURED; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; HUMANS; INSULIN RESISTANCE; MALE; MICE; MIDDLE AGED; OSTEOPONTIN; RATS; RECEPTORS, GASTROINTESTINAL HORMONE; YOUNG ADULT;

EID: 84878250644     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0976     Document Type: Article

References (20)

1. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010;17:332-341
2. Nomiyama T, Perez-Tilve D, Ogawa D, et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 2007;117:2877-2888 (Pubitemid 47529618)
3. Pietiläinen KH, Naukkarinen J, Rissanen A, et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 2008;5:e51
4. Singh M, Ananthula S, Milhorn DM, Krishnaswamy G, Singh K. Osteopontin: a novel inflammatory mediator of cardiovascular disease. Front Biosci 2007;12:214-221 (Pubitemid 46852837)
5. Miyawaki K, Yamada Y, Ban N, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 2002;8:738-742 (Pubitemid 34778728)
6. Yamada C, Yamada Y, Tsukiyama K, et al. Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes. Biochem Biophys Res Commun 2007;364:175-180 (Pubitemid 47599446)
7. Lyssenko V, Eliasson L, Kotova O, et al. Pleiotropic effects of GIP on islet function involve osteopontin. Diabetes 2011;60:2424-2433
8. Isomaa B, Forsén B, Lahti K, et al. A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia 2010;53:1709-1713
9. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470 (Pubitemid 29418240)
10. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - a population-based twin study. Diabetologia 1999;42:139-145 (Pubitemid 29064234)
11. Poulsen P, Vaag A, Beck-Nielsen H. Does zygosity influence the metabolic profile of twins? A population based cross sectional study. BMJ 1999;319:151-154 (Pubitemid 29326896)
12. Brøns C, Jacobsen S, Hiscock N, et al. Effects of high-fat overfeeding on mitochondrial function, glucose and fat metabolism, and adipokine levels in low-birth-weight subjects. Am J Physiol Endocrinol Metab 2012;302:E43-E51
13. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983;55:628-634 (Pubitemid 13044099)
14. Laakso M, Zilinskaite J, Hansen T, et al.; EUGENE2 Consortium. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia 2008;51:502-511
15. Wang J, Kuusisto J, Vänttinen M, et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 2007;50:1192-1200 (Pubitemid 46701561)
16. Honnor RC, Dhillon GS, Londos C. cAMP-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior. J Biol Chem 1985;260:15122-15129 (Pubitemid 16148001)
17. Lewis JT, Dayanandan B, Habener JF, Kieffer TJ. Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist. Endocrinology 2000;141:3710-3716
18. Harada N, Yamada Y, Tsukiyama K, et al. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice. Am J Physiol Endocrinol Metab 2008;294:E61-E68
19. Kiefer FW, Zeyda M, Gollinger K, et al. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 2010;59:935-946
20. Omar B, Banke E, Guirguis E, et al. Regulation of the pro-inflammatory cytokine osteopontin by GIP in adipocytes - a role for the transcription factor NFAT and phosphodiesterase 3B. Biochem Biophys Res Commun 2012;425:812-817